These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31857131)

  • 21. What is new in tics, dystonia and chorea?
    Macerollo A; Martino D
    Clin Med (Lond); 2016 Aug; 16(4):383-9. PubMed ID: 27481387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2.
    García-Ramos R; Santos-García D; Alonso-Cánovas A; Álvarez-Sauco M; Ares B; Ávila A; Caballol N; Carrillo F; Escamilla Sevilla F; Freire E; Gómez Esteban JC; Legarda I; López Manzanares L; López Valdés E; Martínez-Torres I; Mata M; Pareés I; Pascual-Sedano B; Martínez Castrillo JC; Mir P
    Neurologia (Engl Ed); 2021 Mar; 36(2):159-168. PubMed ID: 32980194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tics, tremors and other movement disorders in childhood.
    Blackburn J; Parnes M
    Curr Probl Pediatr Adolesc Health Care; 2021 Mar; 51(3):100983. PubMed ID: 33832853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hyperkinetic movement disorders.
    Bressman SB; Greene PE
    Neurol Clin; 1990 Feb; 8(1):51-75. PubMed ID: 2181268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Brief Review on the Role of Vesicular Monoamine Transporter
    Nikkhah A
    Iran J Child Neurol; 2021; 15(3):29-33. PubMed ID: 34282360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Movement disorders in multiple sclerosis.
    Oakes PK; Srivatsal SR; Davis MY; Samii A
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):639-51. PubMed ID: 24314682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory problems in neurologic movement disorders.
    Mehanna R; Jankovic J
    Parkinsonism Relat Disord; 2010 Dec; 16(10):628-38. PubMed ID: 20674459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Pearls in Tremor and Other Hyperkinetic Movement Disorders.
    Weiss HD
    Semin Neurol; 2016 Aug; 36(4):335-41. PubMed ID: 27643901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.
    Koch J; Shi WX; Dashtipour K
    Pharmacol Ther; 2020 Aug; 212():107580. PubMed ID: 32454050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Movement disorders in pregnancy.
    Ba F; Miyasaki JM
    Handb Clin Neurol; 2020; 172():219-239. PubMed ID: 32768090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scales for hyperkinetic disorders: A systematic review.
    Pietracupa S; Bruno E; Cavanna AE; Falla M; Zappia M; Colosimo C
    J Neurol Sci; 2015 Nov; 358(1-2):9-21. PubMed ID: 26428309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approaches in the management of hyperkinetic movement disorders.
    Fahn S
    Adv Exp Med Biol; 1977; 90():157-73. PubMed ID: 303860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case studies in movement disorders.
    Evidente VG; Caviness JN; Adler CH
    Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of clinical neurophysiology in hyperkinetic movement disorders: A systematic review.
    van der Veen S; Klamer MR; Elting JWJ; Koelman JHTM; van der Stouwe AMM; Tijssen MAJ
    Parkinsonism Relat Disord; 2021 Aug; 89():176-185. PubMed ID: 34362669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progabide in the treatment of hyperkinetic extrapyramidal movement disorders.
    Mondrup K; Dupont E; Braendgaard H
    Acta Neurol Scand; 1985 Sep; 72(3):341-3. PubMed ID: 3864333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Movement Disorders in Children.
    Jain R; Pandey S; Raghav S
    Indian Pediatr; 2021 Sep; 58(9):861-870. PubMed ID: 34016797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-stroke Movement Disorders: Clinical Spectrum, Pathogenesis, and Management.
    Tater P; Pandey S
    Neurol India; 2021; 69(2):272-283. PubMed ID: 33904435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood Neurologic Conditions: Movement Disorders.
    Youssef P
    FP Essent; 2022 Dec; 523():20-26. PubMed ID: 36459665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea.
    Arabia G; De Martino A; Moro E
    Int Rev Neurobiol; 2022; 164():101-128. PubMed ID: 36038202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.